Targeted Genetic Sequencing Analysis of 223 Cases of Pseudomyxoma Peritonei Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Shows Survival Related to GNAS and KRAS Status.
- DOI
- 10.1002/cam4.70340
- Published
- 2024 Oct
- Container
- Cancer medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/cam4.70340,
title = {Targeted Genetic Sequencing Analysis of 223 Cases of Pseudomyxoma Peritonei Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Shows Survival Related to GNAS and KRAS Status.},
author = {Gibson J and Pengelly RJ and Mirandari A and Boukas K and Stanford S and Cecil TD and Mohamed F and Dayal SP and Tzivanakis A and Moran BJ and Mirnezami A and Carr NJ and Ennis S},
year = {2024},
journal = {Cancer medicine},
doi = {10.1002/cam4.70340},
url = {https://doi.org/10.1002/cam4.70340}
}RIS
TY - JOUR TI - Targeted Genetic Sequencing Analysis of 223 Cases of Pseudomyxoma Peritonei Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Shows Survival Related to GNAS and KRAS Status. AU - Gibson J AU - Pengelly RJ AU - Mirandari A AU - Boukas K AU - Stanford S AU - Cecil TD AU - Mohamed F AU - Dayal SP AU - Tzivanakis A AU - Moran BJ AU - Mirnezami A AU - Carr NJ AU - Ennis S PY - 2024 JO - Cancer medicine DO - 10.1002/cam4.70340 UR - https://doi.org/10.1002/cam4.70340 ER -
APA
J, G., RJ, P., A, M., K, B., S, S., TD, C., F, M., SP, D., A, T., BJ, M., A, M., NJ, C., & S, E. (2024). Targeted Genetic Sequencing Analysis of 223 Cases of Pseudomyxoma Peritonei Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Shows Survival Related to GNAS and KRAS Status.. Cancer medicine. https://doi.org/10.1002/cam4.70340
Source records
- pubmed · retrieved 2026-09-26T06:23:15.409Z